Pubblicazioni

Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: a meta-analysis

2019 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Marchetti, C.; De Felice, F.; Perniola, G.; Palaia, I.; Musella, A.; Di Donato, V.; Cascialli, G.; Muzii, L.; Tombolini, V.; Benedetti Panici, P.

Rucaparib. An emerging parp inhibitor for treatment of recurrent ovarian cancer

2018 - CANCER TREATMENT REVIEWS

Musella, Angela; Bardhi, Erlisa; Marchetti, Claudia; Vertechy, Laura; Santangelo, Giusi; Sassu, Carolina; Tomao, Federica; Rech, Francesco; D'Amelio, Renzo; Monti, Marco; Palaia, Innocenza; Muzii, Ludovico; Benedetti Panici, Pierluigi

Beyond circulating microRNA biomarkers: urinary microRNAs in ovarian and breast cancer

2017 - TUMOR BIOLOGY

Gasparri, Maria Luisa; Casorelli, Assunta; Bardhi, Erlisa; Besharat, Aris Raad; Savone, Delia; Ruscito, Ilary; Farooqi, Ammad Ahmad; Papadia, Andrea; Mueller, Michael David; Ferretti, Elisabetta; Panici, Pierluigi Benedetti

Targeting endothelin-1 receptor/ÃÂ²-arrestin1 network for the treatment of ovarian cancer

2017 - EXPERT OPINION ON THERAPEUTIC TARGETS

RosanÃ£Â², Laura; Cianfrocca, Roberta; Sestito, Rosanna; Tocci, Piera; Di Castro, Valeriana; Bagnato, Anna

An overview of early investigational therapies for chemoresistant ovarian cancer

2015 - EXPERT OPINION ON INVESTIGATIONAL DRUGS

Marchetti, Claudia; Ledermann, Jonathan A.; BENEDETTI PANICI, Pierluigi